Tentt

Otsuka Acquires Transcend for $700M

Announced
HealthcarePlatform

Deal Overview

Otsuka has agreed to acquire Transcend in a deal described as $700M, focused on a PTSD drug platform. The transaction is announced as a platform acquisition in the substance-abuse-treatment and mental-health drug space.

Transcend is the target entity in the deal, and Otsuka is the strategic buyer.

Key Details

Transaction
Otsuka acquires Transcend
Deal Size
Over $100M

Source

Read full article on biopharmadive.com

via BioPharma Dive · March 27, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call